New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Lexeo Therapeutics, Inc. (LXEO)
- Autolus Therapeutics PLC Sponsored ADR AUTL 0.91 −7.14%
- Lexeo Therapeutics, Inc. LXEO 2.96 +0.34%
Autolus Therapeutics PLC Sponsored ADR and Lexeo Therapeutics, Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Lexeo Therapeutics, Inc. are of similar size ($267.4M and $260.9M). Across the 10 metrics below, Lexeo Therapeutics, Inc. leads on 7 and Autolus Therapeutics PLC Sponsored ADR on 3.
Valuation
Profitability
| Metric | AUTL | LXEO | Biotechnology median |
|---|---|---|---|
| Gross margin | 35.76% | — | 70.18% |
| Operating margin | (159.61%) | — | 0.00% |
| Net margin | (186.37%) | — | 0.00% |
| Free cash flow margin | (131.12%) | — | 0.00% |
| Return on equity | (174.92%) | (62.39%) | (51.58%) |
| Return on assets | (43.23%) | (54.30%) | (45.91%) |
| Return on invested capital | 0.00% | (324.39%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack